Newsroom

LONDRES--(BUSINESS WIRE)--Balderton annonce aujourd'hui la nomination de Phil Chambers comme associé, où il aura en charge les investissements en phase d'amorçage. Phil rejoint l'entreprise après plus de vingt ans de carrière comme fondateur, dirigeant et investisseur providentiel au sein de l'écosystème technologique européen, notamment à Londres, Hambourg et Copenhague. Plus récemment, il a été CEO d'Orbex, société écossaise de lancement spatial, sélectionnée parmi les cinq lauréats du concou...

Marseille--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société »), une société de biotechnologies au stade clinique qui développe des traitements d’immunothérapies contre le cancer, annonce aujourd’hui que des membres de son équipe de direction participeront à des réunions individuelles lors de la conférence suivante : D. Boral Capital Global Conference Date : 7 mai 2026 Lieu : New York, États-Unis À propos d’Innate Pharma : Inna...

ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News: Azelis Group NV (Brussels:AZE): Highlights Q1 2026 Revenue of EUR 1.0bn, down 0.7% year-on-year in constant currency (-5.2% reported), reflecting a 3.9% organic decline, offset by a 3.3% contribution from acquisitions. Organic performance was underpinned by a solid 4% growth in APAC and broadly stable trends in the Americas, offset by weaker conditions in EMEA. Gross profit of EUR 246m resulting in gross profit margin of 23.7%. The 38 bp gross...

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026 at 1:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the first quarter 2026 financial results on Thursday, May 7, 2026 at 8:30 a.m. ET/2:3...

LONDON--(BUSINESS WIRE)--Balderton gibt heute die Ernennung von Phil Chambers zum Partner bekannt; dort wird er sich auf Investitionen in Unternehmen in der Frühphase konzentrieren. Phil tritt der Firma nach einer über 20-jährigen Karriere als Gründer, Unternehmer und Angel-Investor im europäischen Technologie-Ökosystem bei, wobei er unter anderem in London, Hamburg und Kopenhagen tätig war. Zuletzt war er als CEO von Orbex tätig, einem schottischen Raumfahrtunternehmen, das zu einem der fünf G...

ANTWERPEN, België--(BUSINESS WIRE)--Koersgevoelige Informatie: Azelis Group NV (Brussels:AZE): Hoogtepunten Q1 2026 Omzet van 1,0 miljard EUR, een daling op jaarbasis van 0,7% bij constante wisselkoers (-5,2% gerapporteerd), aangezien de organische daling van 3,9% werd gecompenseerd door een groeibijdrage uit overnames van 3,3%. De organische prestaties werden ondersteund door een solide groei van 4% in APAC en over het algemeen stabiele trends in de Americas, getemperd door minder gunstige oms...

LONDRA--(BUSINESS WIRE)--Balderton oggi annuncia la nomina di Phil Chambers a Partner: ruolo nel quale si concentrerà sugli investimenti iniziali. Phil entra a far parte dell'azienda dopo una carriera di oltre 20 anni come fondatore, operatore e angel investor nell'ecosistema tecnologico europeo, compresi incarichi a Londra, Amburgo e Copenhagen. Più recentemente, Chambers è stato AD di Orbex, la società scozzese di lancio spaziale, selezionata tra i 5 vincitori della European Launcher Challeng...

MARSEILLE, France--(BUSINESS WIRE)--Innate Pharma to participate in the D. Boral Capital Global Conference...

LONDON--(BUSINESS WIRE)--Balderton today announces the appointment of Phil Chambers as Partner, where he will focus on early-stage investments. Phil joins the firm after a 20+ year career as a founder, operator and angel investor in the European technology ecosystem, including roles in London, Hamburg and Copenhagen. Most recently, he served as CEO of Orbex, the Scottish space launch company, which was selected as one of the 5 winners of ESA’s European Launcher Challenge. Prior to Orbex, Phil c...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026. Strong start to the year delivering net sales of 1,473 million USD, predominantly driven by volume and complemented by positive price and mix effects, underscoring the continued execution of its unique, growth-driven integrated dermatology strategy. Widespread net sales growth of 25.5% year-on-year at constant currency1,...